| Primary |
| Nausea |
24.5% |
| Product Used For Unknown Indication |
17.2% |
| Vomiting |
12.6% |
| Drug Use For Unknown Indication |
9.9% |
| Pain |
6.6% |
| Hypertension |
3.3% |
| Infection |
3.3% |
| Migraine |
3.3% |
| Hypocalcaemia |
2.6% |
| Insomnia |
2.6% |
| Depression |
2.0% |
| Abdominal Pain |
1.3% |
| Anxiety |
1.3% |
| Back Injury |
1.3% |
| Constipation |
1.3% |
| Crohn's Disease |
1.3% |
| Drug Exposure During Pregnancy |
1.3% |
| Gastroenteritis |
1.3% |
| Hepatitis C |
1.3% |
| Peritoneal Dialysis |
1.3% |
|
| Tremor |
13.7% |
| Intra-uterine Death |
11.8% |
| Vomiting |
11.8% |
| Wrong Technique In Drug Usage Process |
7.8% |
| Intentional Overdose |
5.9% |
| Pain |
3.9% |
| Pulmonary Oedema |
3.9% |
| Respiratory Distress |
3.9% |
| Sedation |
3.9% |
| Somnolence |
3.9% |
| Speech Disorder |
3.9% |
| Sudden Death |
3.9% |
| Unevaluable Event |
3.9% |
| Urticaria |
3.9% |
| Wound Infection Staphylococcal |
3.9% |
| Acute Respiratory Distress Syndrome |
2.0% |
| Belligerence |
2.0% |
| Confusional State |
2.0% |
| Convulsion |
2.0% |
| Craniocerebral Injury |
2.0% |
|
| Secondary |
| Product Used For Unknown Indication |
30.9% |
| Foetal Exposure During Pregnancy |
17.0% |
| Nausea |
6.9% |
| Migraine |
6.6% |
| Drug Use For Unknown Indication |
5.0% |
| Pain |
4.8% |
| Vomiting |
4.1% |
| Depression |
2.9% |
| Rheumatoid Arthritis |
2.8% |
| Anxiety |
2.0% |
| Insomnia |
2.0% |
| Vertigo |
1.9% |
| Hypertension |
1.8% |
| Prophylaxis |
1.8% |
| Wegener's Granulomatosis |
1.8% |
| Crohn's Disease |
1.7% |
| Psoriasis |
1.7% |
| Drug Exposure During Pregnancy |
1.5% |
| Pregnancy |
1.4% |
| Premedication |
1.4% |
|
| Drug Hypersensitivity |
30.5% |
| Vomiting |
11.4% |
| Premature Baby |
7.6% |
| Tremor |
5.7% |
| Drug Ineffective |
4.8% |
| Agranulocytosis |
3.8% |
| Death |
3.8% |
| Nausea |
2.9% |
| Overdose |
2.9% |
| Speech Disorder |
2.9% |
| Suicide Attempt |
2.9% |
| Tooth Abscess |
2.9% |
| Umbilical Cord Abnormality |
2.9% |
| Weight Decreased |
2.9% |
| White Blood Cell Count Increased |
2.9% |
| Anaphylactic Shock |
1.9% |
| Cardiac Arrest |
1.9% |
| Chills |
1.9% |
| Drug Toxicity |
1.9% |
| Emotional Disorder |
1.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
33.1% |
| Drug Use For Unknown Indication |
12.7% |
| Nausea |
8.8% |
| Pain |
8.6% |
| Depression |
4.2% |
| Crohn's Disease |
3.7% |
| Anxiety |
3.7% |
| Gastrooesophageal Reflux Disease |
3.1% |
| Hypertension |
2.8% |
| Abdominal Pain |
2.4% |
| Migraine |
2.3% |
| Vomiting |
2.1% |
| Contraception |
2.1% |
| Insomnia |
1.8% |
| Constipation |
1.6% |
| Hepatitis C |
1.5% |
| Asthma |
1.4% |
| Prophylaxis |
1.4% |
| Headache |
1.4% |
| Premedication |
1.4% |
|
| Vomiting |
26.4% |
| Weight Decreased |
9.3% |
| Pulmonary Embolism |
7.5% |
| Pain |
7.2% |
| Nausea |
5.4% |
| Weight Increased |
4.4% |
| Suicide Attempt |
3.9% |
| Type 2 Diabetes Mellitus |
3.8% |
| Urinary Tract Infection |
3.5% |
| Ventricular Septal Defect |
3.4% |
| Pyrexia |
3.2% |
| Thrombosis |
2.8% |
| Wrong Technique In Drug Usage Process |
2.8% |
| Pneumonia |
2.7% |
| White Blood Cell Count Increased |
2.7% |
| Deep Vein Thrombosis |
2.5% |
| Pain In Extremity |
2.3% |
| Renal Failure Acute |
2.1% |
| Death |
2.0% |
| White Blood Cell Count Decreased |
2.0% |
|
| Interacting |
| Drug Use For Unknown Indication |
87.5% |
| Multiple Sclerosis |
12.5% |
|
| Drug Interaction |
33.3% |
| Imprisonment |
33.3% |
| Pneumonia |
33.3% |
|
